new
strategi
synthesi
n
benzoylatedand
n
benzyl
n
isato
anhydrid
report
alkyn
appli
cycloaddit
azid
synthes
acycl
nucleosid
obtain
alkyn
evalu
antivir
activ
broad
rang
dna
rna
virus
alkyn
show
activ
ec
mm
compound
also
activ
toward
herp
simplex
wildtyp
thymidin
kinas
defici
tk
strain
ec
valu
rang
mm
addit
compound
exhibit
activ
toward
varicellazost
viru
vzv
tk
tk
strain
ec
mm
compound
prove
select
vzv
display
margin
activ
human
cytomegaloviru
hcmv
although
compound
improv
antihcmv
activ
increas
antihcmv
activ
accompani
signific
toxic
compound
show
inhibitori
effect
toward
human
lymphocyt
cem
cell
line
ic
ae
ae
mm
respect
compound
exhibit
cytostat
activ
toward
cell
ic
ae
mm
acycl
analog
nucleosid
belong
import
class
compound
show
antivir
antitumor
activ
among
acyclovir
penciclovir
exhibit
activ
herp
virus
includ
vzv
hepat
b
viru
hbv
ganciclovir
valganciclovir
prodrug
significantli
improv
oral
bioavail
commonli
use
anticytomegaloviru
agent
howev
case
clinic
applic
nucleosid
limit
due
observ
side
effect
addit
import
problem
treatment
viral
infect
emerg
drugresist
mutant
virus
reason
search
new
antivir
compound
improv
activ
continu
decad
limit
modif
aliphat
chain
also
includ
introduct
addit
group
structur
nucleosid
welldocu
biolog
activ
sinc
moieti
recogn
bioisoster
amid
function
incorpor
structur
motiv
wide
appli
result
broad
spectrum
pharmaceut
import
molecul
furthermor
abl
form
hydrogen
bond
proton
physiolog
ph
also
stabl
oxid
reduct
well
mani
enzymat
reaction
sever
compound
famili
exhibit
broad
spectrum
biolog
activ
antiinflammatori
anticonvuls
antivir
anticanc
antimicrobi
agent
well
blactamas
inhibitor
dopamin
receptor
ligand
relat
schizophrenia
sinc
first
acycl
obtain
lazrek
et
al
mani
effort
made
sever
research
group
synthes
potent
antivir
anticanc
nucleosid
analog
natur
modifi
nucleobas
fig
among
variou
heterocycl
moieti
would
serv
modifi
nucleobas
mimet
substitut
special
interest
structur
motiv
success
attach
variou
biolog
activ
compound
provid
even
activ
hybrid
fig
continu
involv
search
new
biolog
activ
acycl
nucleosid
analog
new
seri
nucleosid
contain
substitut
design
compound
scheme
base
previou
observ
analog
heterocycl
conjug
synthes
research
group
fig
function
benzyl
benzoyl
group
care
select
suitabl
substitu
attach
framework
synthet
strategi
new
seri
present
scheme
start
prepar
yield
accord
literatur
procedur
reaction
benzyl
bromid
gave
yield
initi
consid
respect
n
benzoyl
conveni
substrat
prepar
n
benzoyln
scheme
n
previous
obtain
although
low
less
overal
yield
recent
report
synthesi
n
benzoyln
overal
yield
scheme
howev
procedur
suffer
sever
step
includ
benzoyl
n
n
requir
select
n
debenzoyl
final
propargyl
unfortun
method
select
n
debenzoyl
step
appear
less
effect
tediou
reason
anoth
strategi
synthesi
n
devis
scheme
start
propargyl
commerci
avail
isato
anhydrid
follow
reaction
compound
urea
give
n
final
key
compound
could
transform
substitut
n
benzoyland
n
benzyln
via
reaction
respect
benzoyl
chlorid
benzyl
bromid
scheme
standard
benzoyl
n
benzoyl
chlorid
presenc
triethylamin
led
format
n
benzoyl
n
moder
good
yield
without
format
byproduct
first
attempt
benzyl
n
follow
strategi
previous
describ
synthesi
n
allyl
n
undertaken
treatment
benzyl
bromid
presenc
potassium
hydroxid
h
h
led
format
ca
mixtur
alkyn
allen
total
yield
unfortun
sever
attempt
elabor
effici
procedur
separ
n
benzyln
n
benzyln
silica
gel
column
crystal
prove
fruitless
fortun
abl
chromatograph
isol
small
amount
pure
allen
attempt
optim
procedur
benzyl
therebi
avoid
format
allen
undertaken
thu
treatment
n
benzyl
bromid
presenc
potassium
carbon
dmf
room
temperatur
h
afford
pure
n
benzyln
trace
allen
observ
uisgen
reaction
azid
alkyn
could
accomplish
within
day
reaction
mixtur
heat
howev
reaction
perform
temperatur
microwav
irradi
azid
consum
less
min
reason
cycloaddit
azid
n
n
benzoyl
n
n
benzyl
n
carri
microwav
oven
scheme
disappear
start
azid
monitor
ir
spectroscopi
compound
purifi
chromatograph
crystal
structur
puriti
nucleosid
establish
h
c
nmr
ir
techniqu
well
element
analysi
nd
determin
requir
reduc
virusinduc
cytopathogen
requir
caus
microscop
detect
alter
normal
cell
morpholog
compar
refer
compound
uda
human
corona
viru
measur
ec
mm
mm
respect
moreov
sever
synthes
inhibit
replic
tk
tk
vzv
strain
ec
mm
rang
tabl
particular
alkyn
ec
mm
ec
mm
ec
mm
well
ec
well
ec
mm
show
mark
activ
toward
tk
vzv
strain
higher
refer
drug
acyclovir
brivudin
ec
mm
respect
howev
significantli
less
activ
refer
antivzv
drug
tk
vzv
strain
oka
except
deriv
minimum
cytotox
concentr
mm
howev
compound
cc
mm
cc
mm
well
cc
mm
cc
mm
reduc
cell
growth
measur
cytostat
concentr
ie
cc
lower
concentr
acyclovir
brivudin
cc
mm
result
low
select
ratio
cc
ec
interestingli
emerg
select
antivzv
sinc
inhibit
growth
hel
cell
concentr
mm
synthes
compound
also
subject
antivir
screen
hcmv
among
ec
mm
ec
mm
show
activ
howev
time
show
cytotox
toward
hel
cell
cc
mm
cytostat
activ
test
compound
defin
cytostat
inhibitori
concentr
ic
caus
decreas
cell
prolifer
determin
transform
cell
murin
leukemia
human
lymphocyt
cem
human
cervix
carcinoma
hela
compar
human
dermal
microvascular
endotheli
cell
seri
sever
compound
show
inhibitori
activ
prolifer
tumor
cell
line
tabl
n
benzoylatedand
n
benzyl
n
effici
synthes
isato
anhydrid
copper
catalyz
cycloaddit
azid
select
n
benzoylatedand
n
benzyl
n
microwav
irradi
led
format
acyclonucleosid
well
good
yield
synthes
compound
test
antivir
activ
dna
rna
virus
well
cytostat
activ
cytotox
among
test
compound
ec
mm
show
activ
compar
refer
compound
cidofovir
alovudin
zalcitabin
compound
prove
equal
activ
vzv
tk
tk
strain
addit
deriv
also
inhibitori
tk
tk
vzv
strain
highest
select
ratio
cytostat
effect
cc
antivir
activ
ec
found
compound
cc
mm
mcc
select
compound
low
reduc
cell
growth
cc
among
test
compound
inhibitori
toward
human
tlymphocyt
cem
cell
line
show
inhibitori
effect
ic
ae
ae
mm
respect
compar
refer
compound
ic
ae
mm
compound
exhibit
also
cytostat
activ
ic
ae
mm
toward
cell
line
tabl
inhibitori
effect
test
compound
prolifer
murin
leukemia
cell
human
tlymphocyt
cell
cem
human
cervix
carcinoma
cell
hela
human
dermal
microvascular
endotheli
cell
follow
adsorb
use
column
chromatographi
merck
silica
gel
mesh
analyt
tlc
merck
tlc
plastic
sheet
silica
gel
f
tlc
plate
develop
chloroformmethanol
solvent
system
visual
spot
effect
iodin
vapor
solvent
purifi
method
describ
literatur
microwav
irradi
experi
carri
microwav
reactor
plazmatronika
rm
methylbenzen
n
isato
anhydrid
n
benzoyln
obtain
accord
literatur
procedur
inchi
code
investig
compound
togeth
biolog
activ
data
provid
support
inform
solut
n
isato
anhydrid
ch
c
ch
j
hz
ch
c
ch
gener
procedur
benzoyl
n
suspens
n
mmol
dri
acetonitril
ml
benzoyl
chlorid
mmol
tea
mmol
ad
mixtur
stir
room
temperatur
h
solvent
remov
residu
suspend
dichloromethan
ml
extract
water
ml
organ
phase
dri
mgso
concentr
chromatograph
andor
crystal
give
pure
accord
gener
procedur
n
g
mmol
chlorid
ml
mmol
n
n
g
obtain
white
solid
purif
silica
gel
column
dichloromethan
crystal
chloroformdiethyl
ether
mixtur
ch
c
ch
j
hz
ch
c
ch
gener
procedur
benzyl
n
method
suspens
n
mmol
potassium
hydroxid
mmol
anhydr
acetonitril
ml
benzyl
bromid
mmol
ad
mixtur
stir
h
h
solvent
remov
vacuum
evapor
residu
suspend
dichloromethan
extract
water
ml
organ
phase
dri
mgso
concentr
give
crude
product
mixtur
alkyn
allen
purif
silica
gel
column
chloroform
crystal
chloroformdiethyl
ether
mixtur
gave
mixtur
g
pure
g
white
powder
gener
procedur
benzyl
n
method
b
suspens
n
mmol
anhydr
potassium
carbon
mmol
anhydr
dmf
ml
substitut
benzyl
bromid
mmol
ad
mixtur
stir
room
temperatur
h
water
ml
ad
mixtur
extract
dichloromethan
ml
organ
phase
combin
dri
mgso
concentr
crude
product
purifi
chromatographi
silica
gel
column
crystal
give
accord
gener
procedur
method
b
n
g
mmol
benzyl
bromid
ml
mmol
alkyn
g
obtain
colorless
needl
column
chromatographi
dichloromethan
crystal
chloroformdiethyl
ether
mixtur
accord
gener
procedur
method
b
n
g
mmol
bromid
ml
mmol
product
g
obtain
white
powder
chromatographi
silica
gel
column
dichloromethan
accord
gener
procedur
method
b
n
g
mmol
bromid
ml
mmol
product
g
obtain
white
powder
chromatographi
silica
gel
column
dichloromethan
crystal
chloroformdiethyl
ether
mixtur
gener
procedur
prepar
method
solut
g
mmol
ethanol
ml
h
cuso
mmol
sodium
ascorb
g
mmol
n
g
mmol
ad
mixtur
stir
day
cool
solvent
remov
vacuum
evapor
crude
product
purifi
crystal
water
give
n
methyl
g
colorless
needl
gener
procedur
prepar
method
b
solut
azid
mmol
etoh
ml
h
ml
cuso
mmol
sodium
ascorb
mmol
alkyn
mmol
ad
suspens
irradi
microwav
reactor
plazmatronika
w
min
cool
solvent
remov
residu
suspend
dri
chloroform
ml
filter
layer
celit
solut
concentr
vacuo
crude
product
purifi
silica
gel
column
chloroform
chloroformmethanol
mixtur
vv
crystal
give
accord
gener
procedur
method
b
prepar
g
mmol
n
g
obtain
colorless
needl
crystal
water
accord
gener
procedur
method
b
g
mmol
n
benzoyln
g
obtain
white
powder
purif
silica
gel
chloroform
crystal
chloroformdiethyl
ether
mixtur
